Development of virus-like particle technology from small highly symmetric to large complex virus-like particle structures
P Pushko, P Pumpens, E Grens - Intervirology, 2013 - karger.com
Virus-like particle (VLP) technology is a promising approach for the construction of novel
vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived …
vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived …
African horse sickness: A review of current understanding and vaccine development
African horse sickness is a devastating disease that causes great suffering and many
fatalities amongst horses in sub-Saharan Africa. It is caused by nine different serotypes of …
fatalities amongst horses in sub-Saharan Africa. It is caused by nine different serotypes of …
Insect cell technology is a versatile and robust vaccine manufacturing platform
Baculovirus and insect cell culture technologies have mostly been limited to research
laboratories for the transient expression of target proteins for drug development purposes …
laboratories for the transient expression of target proteins for drug development purposes …
Virus-like particles produced in plants as potential vaccines
N Scotti, EP Rybicki - Expert review of vaccines, 2013 - Taylor & Francis
Virus-like particles (VLPs) have been produced as candidate vaccines in plants virtually
since the introduction of biofarming. Even today, VLPs remain the best candidates for safe …
since the introduction of biofarming. Even today, VLPs remain the best candidates for safe …
Insect cells as a production platform of complex virus-like particles
F Fernandes, AP Teixeira, N Carinhas… - Expert review of …, 2013 - Taylor & Francis
Virus-like particles (VLPs) are multiprotein structures that resemble the conformation of
native viruses but lack a viral genome, potentiating their application as safer and cheaper …
native viruses but lack a viral genome, potentiating their application as safer and cheaper …
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge
E Matsuo, CCP Celma, M Boyce, C Viarouge… - Journal of …, 2011 - Am Soc Microbiol
The reverse genetics technology for bluetongue virus (BTV) has been used in combination
with complementing cell lines to recover defective BTV-1 mutants. To generate a potential …
with complementing cell lines to recover defective BTV-1 mutants. To generate a potential …
Prospects of next-generation vaccines for bluetongue
PA Van Rijn - Frontiers in Veterinary Science, 2019 - frontiersin.org
Bluetongue (BT) is a haemorrhagic disease of wild and domestic ruminants with a huge
economic worldwide impact on livestock. The disease is caused by BT-virus transmitted by …
economic worldwide impact on livestock. The disease is caused by BT-virus transmitted by …
Current strategies for subunit and genetic viral veterinary vaccine development
Developing vaccines for livestock provides researchers with the opportunity to perform
efficacy testing in the natural hosts. This enables the evaluation of different strategies …
efficacy testing in the natural hosts. This enables the evaluation of different strategies …
Current and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations
F Feenstra, PA Van Rijn - Critical reviews in microbiology, 2017 - Taylor & Francis
Bluetongue virus (BTV) causes the hemorrhagic disease bluetongue (BT) in ruminants. The
best way to control outbreaks is vaccination. Currently, conventionally modified-live and …
best way to control outbreaks is vaccination. Currently, conventionally modified-live and …
Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system
SW Metz, GP Pijlman - Journal of Invertebrate Pathology, 2011 - Elsevier
The baculovirus-insect cell expression system is a well-established technology for the
production of heterologous viral (glyco) proteins in cultured cells, applicable for basic …
production of heterologous viral (glyco) proteins in cultured cells, applicable for basic …